Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.
Figures & Tables
Article Information
Vol. 83 No. 8 (1998): August, 1998 : Case Reports
Published
1998-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
Article Usage
Online Views
485
PDF Downloads
129
Statistics from Altmetric.com
No Data
How to Cite
1.
V Roldan Schilling, P Fernandez Abellan, Escribano Dominguez, C Rivas Gonzalez, E Mut Barbera, R Calatayud Cendra. Acute leukemias after treatment with radioiodine for thyroid cancer. Haematologica 1998;83(8):767-768; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
